PLOD1 and hypogonadism: Our study is the first to examine the possible involvement of liver dysfunction/fibrosis in hypogonadism among middle-aged HIV-infected patients, having also the advantage of considering LH levels as marker of hypothalamus–pituitary function and cFT as a more sensitive marker of hypogonadism than TT.